/
Sign inStart free
Menu

Company File · BSE 543748 · Latest filing Q1 FY27

Standalone = this company only. Consolidated = including its subsidiaries.

Aarti Pharmalabs Limited

Data as of 19 Oct 2026 close · BSE · Latest results Q1 FY27

ISIN INE0LRU01027 · AARTIPHARM · Healthcare › Pharmaceuticals & Biotechnology

About the business

What does Aarti Pharmalabs do? It makes active pharmaceutical ingredients, intermediates & xanthine derivatives such as caffeine used in food & drinks. What is an API? The key chemical in a medicine that does the actual work. It also does contract research & manufacturing for global pharma companies. The company was demerged from Aarti Industries & listed in 2023.

Price & valuation · BSE close, 19 Oct 2026

Share price₹833.85▼ 4.7% on the day▼ 1.0% in 1 year
Market cap₹7,561 Cr9.07 crore shares× the latest BSE close
P/E35.5×Usual 30.0×
Above its usual level
PEG–EPS fell 35.9% in a year
Latest filingQ1 FY27
Sales growth
+38.7%
Profit growth
+53.8%
Op. margin
25.4%
P/E
35.5×
Usual P/E
30.0×
Price/book
3.56×
ROCE
11.1%
ROE
9.1%
Debt/equity
0.32×
Promoter
42.86%
Pledged
11.08%

The latest earnings call · Apr to Jun 2026 · transcript filed 17 Aug 2026

The transcript is ready to read; its call notes appear here once they are written.

Transcript

01

Is it expensive, and is it a good business?

Key ratios

Consolidated · price as of 19 Oct 2026

In short Priced above its own usual level (P/E 35.5× vs 30.0×), earns low returns on capital (ROCE 11.1%) and has modest borrowings (debt to equity 0.32×).

What you pay Valuation

Stock P/EAbove usual1-year median 30.0×
35.5×

Buyers pay about ₹35 for every ₹1 the company earned per share over the last year. Above its 1-year median of 30.0×.

Latest BSE close ÷ last four quarters' basic EPS. As of 19th October 2026.

Price to book valueAbove usual1-year median 3.2×
3.56×

The share price is 3.6 times the accounting value of each share. Above its 1-year median of 3.2×.

Latest BSE close ÷ book value per share (equity ÷ shares) on the latest balance-sheet date. As of 19th October 2026.

Price to salesMarket value ÷ yearly sales
3.84×

The market values the company at 3.8 times its yearly sales.

Market value ÷ last 12 months' revenue. As of 19th October 2026.

EV / EBITDAYears of operating profit
19.3×

The whole business (shares plus debt, minus cash) is valued at about 19.3 years of its operating profit.

Enterprise value ÷ last 12 months' EBITDA. As of 19th October 2026.

PEG ratioEPS fell 35.9% in a year
–

EPS fell 35.9% over the latest financial year vs the year before, from ₹30.06 to ₹19.27 a share, so PEG does not apply.

P/E ÷ 12-month EPS growth in % (the last four quarters vs the four before; when those are not all held, the latest financial year vs the year before). Growth above 100% counts as 100%; left blank when EPS fell or was below ₹1 a share a year earlier. Without one-off items when either year has large ones, as for the P/E. As of 19th October 2026.

Dividend yield₹3.50 a share in the last 12 months
0.42%

The company paid ₹3.50 a share in the last 12 months (2 payouts), 0.42% of today's share price.

Dividends per share with an ex-date in the last 12 months (restated for any split or bonus since) ÷ the latest BSE close. As of 19th October 2026.

How well it uses money Returns & strength

ROCE▼ Down from 16.2% a year earlier
11.1%

Each ₹100 of shareholders' money and debt earned about ₹11.1 before interest & tax.

Last 12 months' profit before interest & tax ÷ average (equity + borrowings). As of 31st March 2026.

ROEProfit on shareholders' money
9.1%

For every ₹100 of shareholders' money, the company earned about ₹9.1 in a year.

Last 12 months' profit after tax (continuing operations where reported) ÷ average equity. As of 31st March 2026.

ROICNot in the filings yet
–

Needs reported tax expense that reconciles with profit; not yet available for these periods.

Last 12 months' operating profit after tax (profit before interest & tax × (1 − effective tax rate)) ÷ average invested capital (equity + borrowings − cash & bank balances). As of 31st March 2026.

Asset turnoverSales per ₹1 of assets
0.57×

Every ₹1 of assets generated about ₹0.57 of sales in a year.

Last 12 months' revenue ÷ average total assets. As of 31st March 2026.

Interest coverageTimes profit covers interest
6.04×

Operating profit covered interest costs about 6 times.

Last 12 months' profit before interest & tax ÷ finance costs. As of 30th June 2026.

Debt to equityBorrowings ÷ equity
0.32×

For every ₹1 of shareholders' money, it has borrowed ₹0.32.

Borrowings ÷ shareholders' equity on the latest balance-sheet date. As of 31st March 2026.

Who owns it Ownership & more

Promoter holdingOwned by the promoter group
42.86%

The founders or parent group own 42.86% of the company.

Promoter & promoter group shareholding from the latest shareholding pattern filed with BSE. As of 30th June 2026.

Change in promoter holdingvs the previous quarter
-0.22 pts

Promoter holding fell by 0.22 percentage points last quarter.

Latest quarter's promoter holding minus the previous quarter's. As of 30th June 2026.

Promoter holding, quarter by quarter
  1. Jun 202642.86%
  2. Mar 202643.08%
  3. Dec 202543.10%
  4. Sep 202542.88%
Pledged percentageOf promoter shares · 4.75% of the company
11.08%

Promoters have pledged 11.08% of their shares (43.1 lakh shares), 4.75% of the company.

Promoter group shares pledged ÷ all the promoter group's shares, from the shareholding pattern filed with BSE each quarter (other encumbrances, such as non-disposal undertakings, are not counted). As of 30th June 2026.

Pledged, quarter by quarter
  1. Jun 202611.08%
  2. Mar 202611.03%
  3. Dec 20250.01%
  4. Sep 20250.01%
Free cash flow (latest year)Year to Mar 2026
₹-147 Cr

After paying for new plant & equipment, operations left ₹-147 crore of cash.

Cash from operations − spending on plant & equipment, latest full year. As of 31st March 2026.

Free cash flow, year by year
  1. FY26₹-147 Cr
  2. FY25₹-70 Cr
Face valuePer share
₹5

Each share has a face (nominal) value of ₹5. It matters for dividends quoted as a percentage, not for valuation.

Face value per share as BSE lists it today.

No. of equity sharesCrore shares in issue
9.07 Cr

About 9.07 crore shares were in issue.

BSE's count of listed shares (BSE's market cap ÷ its price), so splits, bonuses & new shares since the latest results are included. As of 19th October 2026.

Tap the i beside any ratio for a plain explanation.

How these are worked out

Price-based ratios use the latest BSE close (19th October 2026). Share count 9.07 crore, from paid-up capital in the 19th October 2026 filing. Figures are consolidated.

What you pay: Higher numbers mean you pay more for each rupee the company earns or owns.

How well it uses money: Higher returns mean each rupee in the business earns more. Lower debt means less strain.

Who owns it: A steady promoter stake with nothing pledged is a calm sign.

+ Add your own ratios

Your choices are remembered on this device.

Last 4 quarters ₹ crore · Consolidated

₹ croreQ2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue from operations418.3432.3582.6535.8
EBITDA74.7102.3113.1136.1
Operating margin17.9%23.7%19.4%25.4%
One-off items–−2.8––
Profit after tax27.948.061.176.1
Profit after tax without one-offs27.950.161.176.1
Basic EPS (₹)3.085.296.748.40

One-off items: exceptional items reported separately in the filing. Profit without one-offs takes them out after tax at 25%.

The full Company File

  • Price, P/E, P/B & returns charts
  • Growth vs last year, explained
  • Cash from operations vs profit
  • Accounts checks
  • Who owns it
  • 8 quarters, balance sheet & cash flow
  • Every BSE filing, in four panels
  • Excel & CSV downloads

Subscribe or sign up free to follow 2 companies

Education & analysis only, not investment advice or a recommendation.

HV Investing Premium

Get the full story on this company

See Premium plans

₹499 a month or ₹4,999 a year. Cancel anytime.

or start free, no card needed

Already a member?Sign in